Breaking News, Collaborations & Alliances

ImmunoPrecise & RIBOPRO Partner for AI-Powered Antibody Discovery

Will integrate RIBOPRO’s advanced mRNA-based antigen expression expertise with IPA’s in silico and wet-lab antibody discovery capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

ImmunoPrecise Antibodies Ltd., an AI-powered antibody discovery and development company, has entered a strategic collaboration with RIBOPRO, a technology provider specializing in mRNA and lipid nanoparticle (LNP) technologies, to accelerate the discovery and development of therapeutic antibodies by integrating RIBOPRO’s advanced mRNA-based antigen expression expertise with IPA’s in silico and wet-lab antibody discovery capabilities. The collaboration leverages RIBOPRO’s expertise in mRNA sequ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters